Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
---|---|
Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
ClinicalTrials.gov Identifier: | NCT00000487 |
To determine for a group of men at high risk of death from coronary heart disease whether a special intervention program to lower serum cholesterol, reduce blood pressure, and eliminate cigarette smoking would result in a significant reduction in mortality from coronary heart disease.
Condition | Intervention | Phase |
---|---|---|
Cardiovascular Diseases Coronary Disease Heart Diseases Myocardial Ischemia |
Drug: antihypertensive agents Behavioral: smoking cessation Behavioral: diet, fat-restricted Drug: diuretics |
Phase III |
Study Type: | Interventional |
Study Design: | Prevention, Randomized |
Ages Eligible for Study: | 35 Years to 57 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Men, ages 35-57. One or more of three risk factors--hypertension, hypercholesterolemia, and cigarette smoking.
Free from coronary heart disease.
Study ID Numbers: | 6 |
Study First Received: | October 27, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00000487 History of Changes |
Health Authority: | United States: Federal Government |
Arterial Occlusive Diseases Coronary Disease Heart Diseases Myocardial Ischemia Diuretics Vascular Diseases |
Cardiovascular Agents Arteriosclerosis Ischemia Antihypertensive Agents Coronary Artery Disease |
Arterial Occlusive Diseases Heart Diseases Myocardial Ischemia Physiological Effects of Drugs Diuretics Vascular Diseases Ischemia Arteriosclerosis Cardiovascular Agents |
Antihypertensive Agents Pharmacologic Actions Coronary Disease Pathologic Processes Natriuretic Agents Therapeutic Uses Cardiovascular Diseases Coronary Artery Disease |